The Lawfare Podcast: Sean Ekins and Filippa Lentzos on a Teachable Moment for Dual-Use

Jen Patja, Tia Sewell, Filippa Lentzos, Sean Ekins
Friday, August 26, 2022, 12:00 PM

Published by The Lawfare Institute
in Cooperation With
Brookings

Back in March, a team of researchers published an article in Nature Machine Intelligence showing that a drug discovery company’s AI-powered molecule generator could have a dangerous dual use: The model could design thousands of new biochemical weapons in a matter of hours that were equally as toxic as, if not more toxic than, the nerve agent VX.

Lawfare associate editor Tia Sewell sat down with two of the paper’s authors: Dr. Filippa Lentzos, senior lecturer in science & international security at the Department of War Studies at King’s College London, and Dr. Sean Ekins, CEO of Collaborations Pharmaceuticals. They discussed the story of their discovery and their reaction to it, as well as how we should think about dual-use artificial intelligence threats more broadly as new technologies expand the potential for malicious use. They also got into why governments need to work more proactively to address the challenges of regulating machine learning software.


Jen Patja is the editor and producer of the Lawfare Podcast and Rational Security. She currently serves as the Co-Executive Director of Virginia Civics, a nonprofit organization that empowers the next generation of leaders in Virginia by promoting constitutional literacy, critical thinking, and civic engagement. She is the former Deputy Director of the Robert H. Smith Center for the Constitution at James Madison's Montpelier and has been a freelance editor for over 20 years.
Tia Sewell is a former associate editor of Lawfare. She studied international relations and economics at Stanford University and is now a master’s student in international security at Sciences Po in Paris.
Dr. Filippa Lentzos is a senior lecturer in the science & international security at the Department of War Studies at King’s College London.
Dr. Sean Ekins is the CEO of Collaborations Pharmaceuticals.

Subscribe to Lawfare